Infection of permissive human cells with human cytomegalovirus (CMV) leads to an ordered sequential expression of viral genes. The first genes expressed after infection are the immediate-early (IE) genes, which require no prior viral protein synthesis. The expression of IE proteins is required for the initiation of early gene expression since infection in the presence of protein synthesis inhibitors prevents subsequent viral gene expression (8, 26, 44, 45) . Studies to date have demonstrated that there are predominantly three distinct segments of the CMV genome expressed at IE times (18, 21, 35, 37, 38, 40, 46) . Originating from one of these segments are two regions of abundant IE gene expression designated IE region 1 (IE1) (37, 40) and IE region 2 (IE2) (38, 40) . These genes are transcribed from a single promoter regulatory region, referred to as the major IE promoter (MIEP), located upstream of IE1 (3, 38, 42) . These two regions code for a family of mRNAs that differ due to splicing and which code for a series of unique but related proteins (35, 38) . IEI codes for the major IE protein which originates from a 1.95-kilobase mRNA (37) . IE2 codes for several proteins, some of which share sequences with IEl (35, 38) . The predominant IE proteins from region 2 are the 86-and 55-kilodalton (kDa) proteins. The 55-kDa protein is expressed only under IE conditions, while the 86-kDa protein persists throughout infection. At late times, a 40-kDa protein is expressed from region 2 (35) .
Numerous studies have shown that IE proteins function in trans activation of promoters (7, 11, 16, 31, 41) . However, all these studies dealt either with nonspecific heterologous viral or cellular promoters or with transfection of cells nonpermissive for CMV. In contrast, Staprans et al. (34) demonstrated that a plasmid containing IEl and IE2 could activate a CMV early promoter in human fibroblast cells. Also, a recent study from our laboratory demonstrated that both IEl and IE2 were necessary for activation of the CMV pp65 promoter (9) . However, the role of specific IEl and IE2 proteins in activating viral gene expression was not addressed in these studies.
To better understand the regulatory role of the IE gene products during infection, we investigated the ability of IEl (1, 2, 3 , and 4) and IE2 (1, 2, 3, 5, 6, and 7) are indicated and as described previously (38) . Sequence is numbered beginning at 40 nucleotides upstream of exon 1 (37) . The construction of pSVCC3, pAcc, and pSVH is as described in the Materials and Methods. The IE promoter (IE Pr) is indicated. (B) Structure of the DNA polymerase gene and promoter fragment (15, 21) . The polymerase promoter from EcoRI (E) to NsiI (N) was cloned into pSVOCAT and used for transfection of HF cells. Map units showing the location of the pol gene and the relative location of the pol mRNA are indicated at the bottom of the figure. kb, Kilobase. (9) . The plasmid pSVH ( Fig. 1 ) was constructed by inserting region 2 into the 3' end of pSVCC3 (9) . The plasmid pAcc was constructed by partial digestion of pSVH with AccI to delete exon 4 of IE1 (9) . The structures of pSVH, pSVCC3, and pAcc are shown in Fig. 1A . pPolCAT (Fig. 1B) was constructed by isolating the EcoRI-to-NsiI fragment containing the DNA polymerase promoter from pCMpol2b (15, 20) . HindIII linkers were added, and the fragment was cloned into pSVOCAT. The plasmid pCAT760 was obtained from M. Stinski and has been described previously (39) . All plasmids were grown and purified as described previously (43) .
Transfection and CAT assays. Transfections with IE plasmids (5 ,ug) and promoter-cat indicator plasmids (5 ,ug) were done as previously described with human fibroblast (HF) cells passaged 1:2 24 h earlier (9) . Cells were harvested at 44 to 48 h after transfection and assayed for chloramphenicol acetyltransferase (CAT) essentially as described previously (9, 14) . Assays were linear for 30 min for up to 50% acetylation.
Mutational analysis. Linker insertion mutants were constructed as described in Fig. 2 . The plasmid pSVH was partially digested with either restriction enzyme FnuDII or HaeIII as previously described (36) . BamHI linkers (CGCG GATCCGCG) (2 ,ug) were added to blunt-ended linear molecules of pSVH ( (30) and used to prime cDNA synthesis. IE cytoplasmic mRNA was prepared as described previously (35, 37, 38) . Approximately 2 ptg of poly(A)-containing IE mRNA was mixed with S ,ug of vector-primer in 25 IL of 50 mM Tris hydrochloride (pH 8.3)-75 mM KCl-5 mM MgCl2-10 mM dithiothreitol-1 mM each dATP, dCTP, dGTP, and dTTP-500 U of Moloney murine leukemia virus reverse transcriptase. After 1 h at 37°C, the reaction was diluted sevenfold in 25 mM Tris hydrochloride (pH 8.3)-75 mM KCl-5 mM MgCl2-250 ,LM dATP-250 ,uM dCTP-250 ,uM dGTP-250 F.M dTTP-5 mM dithiothreitol-250 U of DNA polymerase I per ml-8.5 U of RNase H per ml. The second-strand reaction was incubated at 16°C for 2 h, terminated with 10 mM EDTA, and extracted with phenol-chloroform-isoamyl alcohol (25: 25:1). The vector-cDNA was precipitated with ethanol and resuspended, and one-fifth of the product was ligated overnight at 12°C under standard conditions. The ligation was transformed into E. coli RR1 and plated on L agar containing ampicillin.
Positive clones were selected by colony blot analysis performed as described previously (24) and hybridized to TEl-or IE2-specific probes previously described (35) . Potential IE cDNA clones were subjected to Southern blot analysis and verified by hybridization to IE1 or IE2 probes. cDNAs coding for the IE 72-and 55-kDa proteins were isolated and constructed into a CMV expression vector as described below. These cDNAs were judged "full length" because they contained the SacIT site at +71 in exon 1 and consequently were capable of coding for their complete respective proteins. The 86-kDa cDNA was incomplete in that it terminated in exon 2, 18 amino acids short of the amino terminus. The restriction endonuclease pattern of this cDNA was identical to that of the 55-kDa cDNA with respect to sequences 5' to the IE2 donor splice site which differentiates the 55-and 86-kDa mRNAs (35) .
TEl and IE2 cDNAs were constructed into pSVCC3 and pSVH, respectively, placing the sequences adjacent to their appropriate promoter and 3' ends. For the TEl cDNA (pIE72kd), construction employed the SacII site in exon 1 and the BamHI site in exon 4. For pIE55kd cDNA, the SacII site in exon 1 and the Bsu36I site in the 3' end of IE2 were utilized. To generate the pIE86kd expression vector, the sequences between the SacII and Bsu36I sites in region 2 were excised from the 86-kDa cDNA and cloned into the analogous sites in pIESSkd. This eliminates the spliced-out region characteristic of the 55-kDa cDNA and effectively constructs the 86-kDa cDNA. The structures of the cDNAs and their vectors are shown in Fig. 5A . IE cDNAs were transfected into HF cells either alone or in combination to test their ability to produce IE proteins. The data in Fig. SB indicate that pIE55kd and pIE72kd produced significant quantities of their respective proteins. However, pIE86kd produced low to undetectable levels of protein except in the presence of pIE72kd, when it produced protein at significant levels. Also, in the presence of the 86-kDa protein, the level of the 72-kDa protein was reduced when compared with transfection by pIE72kd alone. The relative levels of the 72-and 86-kDa proteins in a mixed transfection approximate the levels seen in a wild-type infection (35) .
RESULTS
Activation of pPolCAT by IE proteins. To determine the IE2 proteins responsible for activation of pPolCAT, we transfected the IE2 cDNAs either alone or in the presence of pSVCC3, the IEl plasmid. Figure 6A demonstrates that IEl (pSVCC3) and IE2 (pAcc) were necessary for activation of the polymerase promoter. Cotransfection of pSVCC3 with pIE86kd resulted in activation of pPolCAT to levels equivalent to those of pAcc. In contrast, cotransfection of TEl with pIE55kd did not result in a significant increase in promoter activity. Individually, the IE cDNAs failed to stimulate the polymerase promoter to significant levels.
To extend this study, we cotransfected pSVCC3 with increasing quantities of either pAcc or pIE86kd. The data in Fig. 6B indicate that pIE86kd and pAcc behaved identically with respect to their ability to activate the polymerase promoter. DISCUSSION Here we showed that the IE proteins of CMV exhibit promoter-specific differences in their mode of action. tant regions within these proteins involved in mediating these effects. Furthermore, we cloned cDNA recombinants corresponding to three of the most abundant IE proteins to identify and evaluate critically the structure and function of these IE proteins.
Activation of early promoters. Table 1 demonstrates that the regulation of CMV early gene expression, using the DNA polymerase promoter as a model for activation, requires both IE regions 1 and 2. As previously shown, this is also true for the early-late pp65 phosphoprotein gene, which behaves identically in similar assays (9) . Consequently, this may represent a common mechanism for early gene expression during a productive infection. Also, our use of cDNA expression vectors demonstrated that within IE2 the 86-kDa protein is responsible for this activation effect. These results differ from earlier studies with heterologous promoters in either HF (16) or Vero (31) cells which demonstrated that IE2 was sufficient for trans activation of promoters. This may be due to the contribution or interaction of cell-specific factors with heterologous or non-CMV promoters. Also, Chang et al. (4) demonstrated that IE2 could activate a CMV early promoter. However, their data also demonstrated that a plasmid containing both IEl and IE2 activated the CMV early promoter approximately fourfold higher than IE2 alone. This is consistent with our studies (9; this report) which demonstrate low levels of activation of early promoters by IE2 but increased levels of activation by IEl and IE2. Consequently, we conclude that IE1 and IE2 are synergistic in their activation of CMV early promoters.
Activation and repression of MIEP. Earlier studies demonstrated that the 72-kDa protein was capable of downregulating mRNA levels in nonpermissive COS cells and that an IEl carboxy-terminal mutant was incapable of this effect (36 permissive and nonpermissive conditions and this effect is due to cell-specific proteins (29) . Taken together, these observations may implicate cell-specific components in mediating the function of the IE proteins. In particular, the Common and unique domains of IE proteins mediate activation and repression of expression. In an effort to identify the domains responsible for IE protein function, a series of linker insertion mutations were constructed. These mutations were monitored for their ability to influence both IE and early promoter activity. Three key regions were identified as important activation and/or repression domains. The first resides within exon 3 between amino acids 32 and 59 (nucleotides 1194 to 1275) and appears to be specifically required for the activation of the early promoter (Fig. 7) . This exon is leucine-rich, with a general motif of leucine-X3-leucine. However, the significance of these leucine residues has yet to be resolved. In addition, the amino terminus of the IE proteins contains a proline-rich region between amino acids 11 and 25. Other nuclear transcription factors have been shown to contain proline-rich regions (1, 2, 6, 22, 33) , and a recent report by Mermod et al. (27) demonstrates that the proline-rich region of CTF/NF1 corresponds to a transcriptional activation domain.
A second potential domain resides within exon 4 and is exclusive to the 72-kDa protein. An examination of the primary sequence structure of this exon demonstrates that a single putative zinc finger (17, 28, 32) is located in approximately the center of exon 4 (amino acids 266 to 285) (Fig. 7) . The importance of a single zinc finger in the 72-kDa protein is not clear. Another sequence motif present in exon 4 is a leucine zipper (23) which exists adjacent to the zinc finger structure (amino acids 294 to 325) (Fig. 7) . This motif appears to promote protein-protein interactions to effect DNA binding. Whether or not this region is capable of forming a leucine zipper structure must await further experimentation. Exon 4 also contains segments of polyglutamic acid, which may form potential acidic activation domains, as well as polyserine stretches, which form potential sites for phosphorylation (13, 19, 47, 48) . These homologies may indicate that several distinct units exist within the protein which interact with each other.
The third domain resides within IE region 2 between amino acids 359 and 540 (nucleotides 3721 to 4262). These sequences encompass a putative zinc finger distinct from that present in the 72-kDa protein as well as a leucine-rich domain which weakly conforms to a leucine zipper motif (Fig. 7) . This region serves as both an activator of the early promoter and a repressor of the IE promoter. We could not distinguish in the present study whether the activation and repression domains are identical or overlap. However, it does appear that the two mutants that define this domain are phenotypically identical. Clearly, common and unique protein domains within the IE proteins are involved in mediating activation and repression.
Finally, both proteins contain potential nuclear localization signals which are characterized by the clustering of four to six basic amino acids (10) as well as potential N-linked glycosylation sites (25) . The locations of the putative regulatory domains relative to the IE proteins are summarized in Fig. 7 .
Structure and function of 72-, 86-, and 55-kDa proteins. To determine which IE2 proteins were responsible for activation and/or repression, we isolated cDNA clones corresponding to the predominant IE proteins of 72, 86, and 55 kDa. An analysis of the structure of these clones confirmed our previous observations on the splicing of the IE mRNAs (35, 37, 38) . Our studies clearly demonstrated that the 72-kDa protein plays a key role in the activation process. Furthermore, this protein dominantly suppresses the repression effects of the IE2 proteins. The 86-kDa protein is responsible for both the activation and repression effects on the early pol promoter and the MIEP, respectively. Mutations in the 86-kDa protein (m13 and m14) affect early promoter activation and IE promoter repression and lead to an increased level of all the IE proteins. The difference in structure between the 55-and 86-kDa IE proteins lies within the IE2 intron, which is an integral component of the 86-kDa protein. This region contains the putative zinc finger and a leucine-rich region (Fig. 7) . This strongly associates these regions with the activation-repression by the 86-kDa protein and agrees with the mutagenesis study. These experiments also clearly demonstrated the presence of multiple functional domains within the IE gene region as well as multiple protein involvement in regulating CMV gene expression.
Model for IE protein function. The differential effect of IE proteins on IE and early gene expression in permissive and nonpermissive cells may assist our understanding of the potential mechanisms involved in latency. Negative regulation of the IE promoter by TEl and IE2 gene products in nonpermissive cells may (i) result in insufficient expression of IE gene products necessary for the maintenance of the replicative cycle or (ii) disrupt the balance of IE gene products, resulting in improper activation of early and late promoters. Our studies demonstrate that the 72-and 86-kDa IE proteins interact to regulate subsequent CMV gene expression (Fig. 8) . While the 86-kDa IE protein is involved in both activation and repression, it is clear that its expression is regulated by the presence of the 72-kDa IE protein. This implies that the level of the 72-kDa protein produced in the infected cell is the determining factor in the commitment to activation or repression.
